What do they prescribe for the flu when symptoms become moderate to severe? Clinicians usually consider prescription options when someone is at higher risk of complications or has a severe or rapidly worsening course. Antiviral medications, such as oseltamivir (Tamiflu), zanamivir (Relenza), and baloxavir (Xofluza), are the mainstay of prescription care for influenza, working best when started within the first 48 hours of symptom onset. Providers may also prescribe short-term therapies for fever, cough, and congestion to improve comfort while the immune system clears the virus. The following sections detail common prescriptions, how they are chosen, and when they are most helpful.
Key Antiviral Options for Influenza
For people who benefit from medication, prescription antiviral drugs can shorten the duration of symptoms and lower the risk of complications when taken early. These medications target the influenza virus directly and are different from symptom-relieving treatments. Eligibility depends on age, risk factors, timing of symptom onset, and local resistance patterns. Below is a concise comparison of commonly used antivirals for confirmed or strongly suspected influenza.
Oseltamivir (Tamiflu)
Oseltamivir is an oral neuraminidase inhibitor available in capsule and liquid forms. It is widely used across age groups, including in pregnant individuals when benefits outweigh potential risks. Typical treatment courses last five days, though providers may adjust duration for severe cases or immunocompromised patients. Oseltamivir can reduce the length of illness by roughly one day when started within 48 hours and may lessen complications such as otitis media in children and lower respiratory complications in adults.
Zanamivir (Relenza)
Zanamivir is an inhaled neuraminidase inhibitor approved for treatment in people aged 7 years and older. Because it is not recommended for those with underlying respiratory conditions such as asthma or COPD, its use is more limited than oseltamivir. Administered via a disk inhaler, zanamivir acts locally in the respiratory tract and, like oseltamivir, is most effective when initiated early. Studies indicate similar efficacy to oseltamivir for uncomplicated influenza in suitable candidates.
Baloxavir (Xofluza)
Baloxavir is a cap-dependent endonuclease inhibitor available as a single-dose oral tablet. It is approved for people aged 12 years and older who have been symptomatic for no more than 48 hours. By halting viral replication early, baloxavir can noticeably shorten symptom duration and reduce viral shedding. Its once-dose convenience is advantageous, but higher costs and limited long-term resistance data are considered in treatment decisions.
When Antivirals Are Recommended
Prescription antiviral use is often prioritized for individuals at higher risk of influenza-related complications. For otherwise healthy adults with mild symptoms and no risk factors, clinicians may choose to focus on supportive care rather than antiviral therapy. In contrast, patients who are hospitalized, have severe disease, or belong to high-risk groups are more likely to be prescribed antivirals, regardless of how much time has passed since symptom onset.
High-Risk Groups
- Adults and children with chronic lung or heart disease
- People with metabolic conditions such as diabetes
- Individuals with weakened immune systems due to disease or treatment
- Pregnant and postpartum individuals
- Residents of long-term care facilities
- People aged 65 years and older
Symptom-Relief Prescriptions
In addition to antivirals, clinicians may prescribe short-term medications to manage distressing symptoms. These prescriptions do not shorten illness duration but can improve comfort and hydration. Cough suppressants, stronger analgesics, or inhaled bronchodilators may be used when symptoms are severe or when over-the-counter options are insufficient or not tolerated.
Common Symptom-Relief Options
- Short courses of narcotics for severe cough when other measures fail
- Prescription-strength NSAIDs or acetaminophen for high fever and myalgia
- Inhaled bronchodilators for wheeze or underlying asthma
What to Expect in a Clinical Visit
When you seek care for suspected influenza, a provider will assess your symptoms, review risk factors, and determine whether testing is appropriate. Rapid influenza diagnostic tests can support clinical judgment, though results may be false-negative. Decisions about what do they prescribe for the flu often hinge on how soon symptoms began, the severity of illness, and underlying health conditions. If prescribed, antivirals are typically taken for five days, with symptom monitoring to guide further care.
Potential Side Effects and Safety Considerations
All prescription medications carry potential side effects, and clinicians weigh benefits against risks before issuing a treatment plan. Nausea, headache, and bronchospasm are among the most commonly reported effects associated with influenza antivirals. For symptom-relief prescriptions, risks vary by medication class and patient comorbidities. Open discussion with your clinician can help ensure that prescribed treatments align with your overall health profile.
Limitations and Evolving Guidance
Evidence about influenza treatment continues to evolve, and recommendations may change as new data on resistance patterns, safety, and outcomes emerge. Not every case of influenza requires a prescription, and antiviral use is most beneficial when started early in high-risk individuals. Staying up to date with annual vaccination remains the most effective long-term strategy to reduce the burden of flu and the need for prescription interventions.
Summary Comparison of Common Prescriptions for Influenza
| Medication | Key Features | Typical Duration | Prescription Context |
|---|---|---|---|
| Oseltamivir (Tamiflu) | Oral, widely used, suitable for many age groups | 5 days (may vary) | First-line antiviral for treatment and post-exposure prophylaxis |
| Zanamivir (Relenza) | Inhaled, for ages 7+, not for asthma/COPD | 5 days | Alternative for patients who cannot take oral antivirals |
| Baloxavir (Xofluza) | Single-dose oral, for ages 12+, within 48 hours | 1 dose | Convenient option for early treatment in eligible patients |
Conclusion
When clinicians consider what do they prescribe for the flu, they typically focus on antivirals for at-risk patients or those with severe or rapidly progressing illness, combined with targeted symptom relief when needed. Antiviral choices depend on age, renal and respiratory function, pregnancy status, and timing of symptoms. Understanding these options can help you participate actively in shared decision-making and use prescribed therapies safely and effectively.